Efficient Drug Development
Powered By

  • Expert Management for Innovative and Agile Drug Development

  • Strategic Program Design

  • Phase-Specific Program Creation

  • Proactive Financial Planning

  • Strategic Exit Considerations

InnoDev Delivers Efficient Drug Development Through Strategic Planning and Collaboration

Blank white background
Scientist in a laboratory working with test tubes, wearing protective gear and gloves, surrounded by computers and lab equipment. Laboratory shelves in the background hold various scientific instruments and supplies.

Strategic Program Design

  • Thorough due diligence

  • Comprehensive development plans based on precedent strategies, regulatory guidelines, gap analysis, unmet medical need and market opportunity

  • Target Product Profiles created at outset, defining key differentiators, competitive advantages and setting benchmarks for success

Animated person with large eyes and fixed stare, wearing dark clothing with a striped tie, standing against a neutral background.
FDA building with sign for U.S. Department of Health and Human Services Food and Drug Administration

Phase Specific Program Creation

  • Optimal development path, identifying key studies early in program to define position in market and facilitate early go/no go decisions

  • Ongoing regulatory assessment

  • Ensure alignment between scientific goals and business objectives

Business meeting with digital tablet displaying graphs, papers, calculator, and people discussing data.
A woman wearing a zebra print outfit with a matching hat, holding a microphone and posing with a lively expression.

Proactive Financial Planning

  • Realistic and size-optimal budgets that support program development and offer return on investment at critical junctures

  • Clearly identified value inflection points throughout development

  • Ongoing support to capital expansion efforts, including IPO planning

Two businessmen shaking hands in a brightly lit office with large windows.
White musical note on red background

Strategic Exit Considerations

  • Evaluate potential exit strategies for individual programs or entire companies

  • Align exit plans with overall business strategy and investor expectations

Close-up of gloved hands using a syringe to draw liquid from a vial.

Expert Management for Innovative and Agile Drug Development

  • Assemble an expert, integrated team across drug discovery, development, regulatory and commercial

  • Design efficient development programs that maximize value inflections and build in commercial readiness

  • Drive day-to-day decision-making through cross-functional collaboration and effective communication and planning; Strategic process and approach empowers team to advance the development program

  • Build asset value without full company formation

  • Adapt quickly to changing project needs

  • Optimize resource allocation

  • Maximize innovation and efficiency in drug development

Our flexible structure allows us to: